PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of liphdisBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleLipids in Health and DiseaseJournal Front Page
 
From:
Published online 2010 July 15. doi: 10.1186/1476-511X-9-72

Table 2

Hemodynamic data for healthy adults consuming Capsimax™ and placebo in a randomized cross-over design

VariablePre1 hr2 hr
(pre-ex)
2.5 hr
(1 min post ex)
3 hr
(30 min post ex)
4 hr
(90 min post ex)
HR (bpm)
Capsimax™
58 ± 1257 ± 1158 ± 11115 ± 17*73 ± 1465 ± 15
HR (bpm)
Placebo
60 ± 1257 ± 1158 ± 13114 ± 14*73 ± 1465 ± 13
SBP (mmHg)
Capsimax™
112 ± 8114 ± 8115 ± 11140 ± 16*115 ± 8113 ± 12
SBP (mmHg)
Placebo
112 ± 11114 ± 11116 ± 10141 ± 16*112 ± 11111 ± 9
DBP (mmHg)
Capsimax™
72 ± 772 ± 672 ± 764 ± 10*67 ± 770 ± 8
DBP (mmHg)
Placebo
71 ± 1070 ± 770 ± 964 ± 10*66 ± 868 ± 8

Data are Mean ± SD

No condition x time interaction or condition effect was noted for HR, SBP, or DBP (p > 0.05).

*A time effect was noted for all variables (p < 0.05); HR and SBP higher than Pre at 2.5 hr; DBP lower than Pre at 2.5 hr.

HR-heart rate; SBP-systolic blood pressure; DBP-diastolic blood pressure